WHO ICTRP trial
A Study of Bone Mineral Density in HIV Infected Subjects
EUCTR2011-004420-35-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-004420-35-BE |
|---|---|
| Public title | A Study of Bone Mineral Density in HIV Infected Subjects |
| Scientific title | A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects |
| Primary sponsor | Gilead Sciences, Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Portugal;Spain;Ireland;Austria;Switzerland;United Kingdom;Italy;France;Belgium;Poland;Germany;Netherlands;Sweden |
| Conditions | Human Immunodeficiency Virus-1 (HIV-1) Infections MedDRA version: 14.1 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Immune System Diseases [C20] |
| Interventions | Trade Name: Viread Pharmaceutical Form: Film-coated tablet INN or Proposed INN: TENOFOVIR DISOPROXIL FUMARATE CAS Number: 202138-50-9 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 300- Trade Name… |
| Registration date | Apr 12, 2012 |
| Target size | 480 |
| Secondary IDs | GS-US-104-0423 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: